Safety and Tolerability of the Treatment of Youth-Onset Type 2 Diabetes: The TODAY experience

OBJECTIVE: Data related to the safety and tolerability of treatments for pediatric type 2 diabetes are limited. The TODAY clinical trial assessed severe adverse events (SAEs) and targeted nonsevere adverse events (AEs) before and after treatment failure, which was the primary outcome (PO). RESEARCH...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661822/
https://www.ncbi.nlm.nih.gov/pubmed/23704676
http://dx.doi.org/10.2337/dc12-2390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661822/
https://www.ncbi.nlm.nih.gov/pubmed/23704676
http://dx.doi.org/10.2337/dc12-2390

Ejemplares similares